Sponsor
Vesper Bio ApS
4th Floor, Hauser Plads 10, 1127 Copenhagen, Denmark
About the sponsor
Vesper Bio ApS focuses on clinical research in frontotemporal dementia (FTD), with particular attention to GRN-associated FTD and participants at risk of developing symptoms. Its trial activity centers on disease areas linked to inherited neurodegenerative conditions and early clinical intervention.
- GRN-related neurodegeneration
- Asymptomatic FTD
- Inherited dementia syndromes
The sponsor’s research landscape is concentrated in neurology, especially conditions involving progressive cognitive and behavioral decline associated with FTD.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.